NARECHEM-ST ongoing Case/Control Study

  • Selection matched hospital controls by age and gender: For every child with leukemia/lymphoma, a suitable control is individually matched on age (± 6 months) and sex among those hospitalized for minor pediatric ailments at the same time as the corresponding cases
    • The guardians of all eligible children are informed of the registry/study objectives and interviewed in person using a structured electronically available questionnaire
      • Conduct of epidemiological studies